• About WordPress
    • WordPress.org
    • Documentation
    • Learn WordPress
    • Support
    • Feedback
  • Log In
  • Register
Skip to content
Endocannabinoid Science Education Endocannabinoid Science Education

ECS is Physiology

  • What?
  • Why?
  • How?
  • Where?
  • Contact
  • Advisory Board
  • Forums
  • Blog
  • Bio
  • ECS Explained
Endocannabinoid Science Education
Endocannabinoid Science Education

ECS is Physiology

Tag: Anandamide

Critical analysis Wide scientific illustration showing dietary linoleic acid progressing through plasma and red blood cell biomarkers to tissue arachidonic acid and downstream endocannabinoid signaling through 2-AG, anandamide and CB1.

Linoleic Acid Is Not One Exposure: Blood Levels, Arachidonic Acid and Tissue Biology

Posted on October 24, 2026October 24, 2026 By Stefan Broselid

A new review argues that higher linoleic acid exposure may be beneficial. But dietary intake, circulating LA and tissue fatty-acid composition are not the same biological exposure. This article explains why that distinction matters for arachidonic acid, membrane biology and the endocannabinoid system.

Read more
Endocannabinoid System (ECS) Scientific illustration showing metabolic dysfunction in visceral adipose tissue increasing 2-AG and anandamide production, while hyperinsulinemia is associated with increased CB1 receptor stability. Both pathways converge on a central CB1 receptor embedded in a cell membrane.

When Metabolic Dysfunction Acts on Both Sides of CB1 Signalling

Posted on October 6, 2026October 6, 2026 By Stefan Broselid

A new Diabetologia study shows that insulin-resistant visceral adipose tissue overproduces 2-AG and anandamide, while recent work suggests insulin can also increase CB1 receptor stability. Together, these findings raise a testable question: can metabolic dysfunction amplify CB1 signalling by increasing both endogenous ligand production and receptor abundance?

Read more
Fatty Acid Research ECS.education illustration showing the pathway from dietary fat intake through metabolic processing to the achieved DBS/RBC fatty-acid profile, membrane substrate architecture, and endocannabinoid lipid signalling, emphasizing that what is eaten is not the same as the substrate state ultimately achieved.

Your ECS Runs on What Your Metabolism Does With What You Eat

Posted on October 2, 2026October 2, 2026 By Stefan Broselid

New human tracer data show that the same dietary fatty-acid exposure can produce very different biological outcomes depending on metabolic state. For the endocannabinoid system, this strengthens the case for measuring achieved DBS/RBC fatty-acid profiles rather than assuming intake equals substrate availability.

Read more
Commentary Conceptual illustration showing membrane fatty-acid state as a baseline biological condition, followed by an endurance running challenge and distinct arachidonate/endocannabinoid responses involving AEA, arachidonic acid and 2-AG. A red blood cell and phospholipid membrane represent longer-term fatty-acid status, a runner represents prolonged exercise, and non-quantitative signal traces represent the time-dependent ECS response. ECS.education logo appears in the upper right.

The missing membrane layer in a new marathon endocannabinoid study

Posted on September 3, 2026September 3, 2026 By Stefan Broselid

A new BMC Medicine study shows that marathon running triggers distinct temporal changes in anandamide, 2-AG and arachidonic acid. The missing piece may be the runners’ membrane fatty-acid state before exercise.

Read more
Endocannabinoid System (ECS)

Your ECS Under Load: Regular Cannabis, Exercise, and a Blunted Runner’s High

Posted on March 2, 2026March 2, 2026 By Stefan Broselid

Your ECS under load, not at rest Most cannabis conversations live in the acute space: “How does it feel when I’m high?” or in vague long‑term boxes like “motivation” or “psychosis risk.” Almost nobody asks the more mechanistic question that actually matters for resilience:​ What does your endocannabinoid system do…

Read more
Critical analysis Divided illustration contrasting mainstream omega-6 fatty acid research on left with neglected endocannabinoid system CB1 CB2 receptor pathways anandamide 2-AG hidden behind broken wall on right alongside cannabis leaf and ignored research files

The Missing System: How a Major 2026 Review on Cardiometabolic Health Ignores the Endocannabinoid System

Posted on February 2, 2026February 2, 2026 By Stefan Broselid

Last August, I wrote about a troubling pattern in inflammation research: brilliant scientists studying arachidonic acid metabolism while remaining “blissfully unaware that half the arachidonic acid story exists in a parallel research universe.” I documented how eicosanoid researchers and endocannabinoid scientists study the same substrate, same concentration ranges, same tissues—yet publish in…

Read more
Endocannabinoid System (ECS) Three-panel scientific illustration comparing endocannabinoid system function across three dietary states. Left panel: High omega-6 diet showing excess CB1 receptor stress and 2-AG/AEA production (omega-6:omega-3 ratio 20:1). Center panel: Optimized substrates with balanced membrane composition supporting multiple endocannabinoid types and receptor function. Right panel: High omega-3 diet showing activated TRPV1/TRPA1 ion channels, PPARα activation, and anti-inflammatory endocannabinoid production (omega-3:omega-6 ratio 4:1). Bottom tagline: Substrate availability dictates endocannabinoid system function.

2025 in ECS Research: The Year the Substrate-Driven ECS Model Came of Age

Posted on December 28, 2025December 28, 2025 By Stefan Broselid

Endocannabinoid system substrate—specifically membrane fatty acid composition—is the primary determinant of CB1 receptor function, not genetics or receptor density. For years, I’ve been making the case that endocannabinoid system function is not primarily about receptor density or genetic variants, it’s about substrate availability. The composition of fatty acids in cell…

Read more
Endocannabinoid System (ECS) Soybean oil and linoleic acid tipping gut lipid balance: diagram showing linoleic acid driving arachidonic acid toward eicosanoids while endocannabinoids decrease, with a bottle of soybean oil and soybeans.

Soybean oil, linoleic acid, and the gut ECS

Posted on September 19, 2025September 19, 2025 By Stefan Broselid

A recent study titled ‘Diet high in linoleic acid dysregulates the intestinal endocannabinoid system and increases susceptibility to colitis in Mice‘ shows that eating a lot of linoleic acid from soybean oil changes lipid chemistry in the gut in a way that weakens the protective endocannabinoid system and strengthens inflammatory…

Read more
Commentary

Seeing is Believing: New Tech Reveals How The Endocannabinoid System Works in Real-Time

Posted on May 6, 2025 By Stefan Broselid

A paradigm-shifting review in Neuron (Malhotra et al., 2025) highlights how new technologies allow scientists to visualize endocannabinoid (ECS) dynamics in real-time in behaving animals. This post breaks down the key breakthroughs, including the central role of 2-AG in rapid signaling, its precision, its function in memory and seizures, and the implications for healthcare professionals and medical cannabis.

Read more
Scientific Summary

A Paradigm-Shift in Endocannabinoidome Pharmacology – Adenylyl Cyclases as Lipid-Sensing Receptors

Posted on February 4, 2025February 4, 2025 By Stefan Broselid

Introduction: A New Role for Dietary Fats For decades, fats have been categorized as either “good” or “bad,” depending on their effects on cholesterol or calorie counts. However, groundbreaking research by Landau etal. (2024) reveals that fats are far more than energy sources—they act as cellular signalsthat directly influence how our cells function. The study shows that adenylyl cyclases (ACs)—enzymes traditionally…

Read more
©2026 Endocannabinoid Science Education | WordPress Theme by SuperbThemes